Cargando…

481. Evolution of Carbapenem-Resistant Pseudomonas aeruginosa (CR-PA) Genetic Lineages and Acquisition of β-Lactamase Enzymes

BACKGROUND: Nosocomial infections due to CR-PA are associated with significant morbidity and mortality, and knowledge of epidemiology and underlying mechanisms of antimicrobial resistance is critical to addressing this threat. Recently, we identified a CR-PA of sequence type (ST) 309 resistant to al...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Aki, Dinh, An Q, Hanson, Blake, Shropshire, William C, Tran, Truc T, Wanger, Audrey, Arias, Cesar A, Miller, William R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811033/
http://dx.doi.org/10.1093/ofid/ofz360.554
_version_ 1783462380716425216
author Sakurai, Aki
Dinh, An Q
Hanson, Blake
Shropshire, William C
Tran, Truc T
Wanger, Audrey
Arias, Cesar A
Miller, William R
author_facet Sakurai, Aki
Dinh, An Q
Hanson, Blake
Shropshire, William C
Tran, Truc T
Wanger, Audrey
Arias, Cesar A
Miller, William R
author_sort Sakurai, Aki
collection PubMed
description BACKGROUND: Nosocomial infections due to CR-PA are associated with significant morbidity and mortality, and knowledge of epidemiology and underlying mechanisms of antimicrobial resistance is critical to addressing this threat. Recently, we identified a CR-PA of sequence type (ST) 309 resistant to all available β-lactams due to acquired β-lactamases as a potential emerging clone. To assess the evolving landscape of resistance in CR-PA we performed a cross-sectional survey of historical and contemporary isolates utilizing phenotypic testing and whole-genome sequencing (WGS). METHODS: Historical CR-PA isolates (n = 61, collected from 1999 to 2015) and contemporary isolates (n = 110, collected from 2017 to 2018) from a large urban hospital network in Houston, TX were tested for susceptibility to meropenem, aztreonam (ATM), ceftolozane/tazobactam (C/T), and ceftazidime/avibactam (CZA) using E-test on Mueller–Hinton (MH) agar. WGS for all isolates was performed on a MiSeq platform (Illumina). Data analysis was performed using a custom analysis pipeline, including Tseemann MLST tool, Resfinder, and Abricate using the CARD database. RESULTS: The prevalence of resistance across all β-lactams tested increased in contemporary strains as compared with that of historical strains (Figure 1). Among important contemporary antipseudomonal antibiotics C/T, ATM, and CZA, resistance increased from 0%, 22%, and 5% to 15%, 44%, and 16%, respectively (Figure 1). WGS revealed that ST235 was the most common sequence type, followed by ST111 in the historical collection (Figure 2). In contrast, a larger degree of genetic diversity was found in contemporary isolates, with the emergence of multidrug-resistant clones such as ST308 (2%) and ST309 (3%). Resistance to C/T was associated with acquired β-lactamases in 88% (14/16) of isolates, including VIM-2, GES-19/GES-26, VEB-1, NMD-1, and OXA enzymes. CONCLUSION: Resistance to newer agents C/T and CZA markedly increased in contemporary CR-PA strains. While the epidemic clones ST235 and ST111 were the most frequent STs, ST308 and 309 have emerged among contemporary MDR isolates. Most concerning was the association of C/T resistance and the acquisition of β-lactamases, due to the potential for further dissemination. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6811033
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68110332019-10-28 481. Evolution of Carbapenem-Resistant Pseudomonas aeruginosa (CR-PA) Genetic Lineages and Acquisition of β-Lactamase Enzymes Sakurai, Aki Dinh, An Q Hanson, Blake Shropshire, William C Tran, Truc T Wanger, Audrey Arias, Cesar A Miller, William R Open Forum Infect Dis Abstracts BACKGROUND: Nosocomial infections due to CR-PA are associated with significant morbidity and mortality, and knowledge of epidemiology and underlying mechanisms of antimicrobial resistance is critical to addressing this threat. Recently, we identified a CR-PA of sequence type (ST) 309 resistant to all available β-lactams due to acquired β-lactamases as a potential emerging clone. To assess the evolving landscape of resistance in CR-PA we performed a cross-sectional survey of historical and contemporary isolates utilizing phenotypic testing and whole-genome sequencing (WGS). METHODS: Historical CR-PA isolates (n = 61, collected from 1999 to 2015) and contemporary isolates (n = 110, collected from 2017 to 2018) from a large urban hospital network in Houston, TX were tested for susceptibility to meropenem, aztreonam (ATM), ceftolozane/tazobactam (C/T), and ceftazidime/avibactam (CZA) using E-test on Mueller–Hinton (MH) agar. WGS for all isolates was performed on a MiSeq platform (Illumina). Data analysis was performed using a custom analysis pipeline, including Tseemann MLST tool, Resfinder, and Abricate using the CARD database. RESULTS: The prevalence of resistance across all β-lactams tested increased in contemporary strains as compared with that of historical strains (Figure 1). Among important contemporary antipseudomonal antibiotics C/T, ATM, and CZA, resistance increased from 0%, 22%, and 5% to 15%, 44%, and 16%, respectively (Figure 1). WGS revealed that ST235 was the most common sequence type, followed by ST111 in the historical collection (Figure 2). In contrast, a larger degree of genetic diversity was found in contemporary isolates, with the emergence of multidrug-resistant clones such as ST308 (2%) and ST309 (3%). Resistance to C/T was associated with acquired β-lactamases in 88% (14/16) of isolates, including VIM-2, GES-19/GES-26, VEB-1, NMD-1, and OXA enzymes. CONCLUSION: Resistance to newer agents C/T and CZA markedly increased in contemporary CR-PA strains. While the epidemic clones ST235 and ST111 were the most frequent STs, ST308 and 309 have emerged among contemporary MDR isolates. Most concerning was the association of C/T resistance and the acquisition of β-lactamases, due to the potential for further dissemination. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6811033/ http://dx.doi.org/10.1093/ofid/ofz360.554 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Sakurai, Aki
Dinh, An Q
Hanson, Blake
Shropshire, William C
Tran, Truc T
Wanger, Audrey
Arias, Cesar A
Miller, William R
481. Evolution of Carbapenem-Resistant Pseudomonas aeruginosa (CR-PA) Genetic Lineages and Acquisition of β-Lactamase Enzymes
title 481. Evolution of Carbapenem-Resistant Pseudomonas aeruginosa (CR-PA) Genetic Lineages and Acquisition of β-Lactamase Enzymes
title_full 481. Evolution of Carbapenem-Resistant Pseudomonas aeruginosa (CR-PA) Genetic Lineages and Acquisition of β-Lactamase Enzymes
title_fullStr 481. Evolution of Carbapenem-Resistant Pseudomonas aeruginosa (CR-PA) Genetic Lineages and Acquisition of β-Lactamase Enzymes
title_full_unstemmed 481. Evolution of Carbapenem-Resistant Pseudomonas aeruginosa (CR-PA) Genetic Lineages and Acquisition of β-Lactamase Enzymes
title_short 481. Evolution of Carbapenem-Resistant Pseudomonas aeruginosa (CR-PA) Genetic Lineages and Acquisition of β-Lactamase Enzymes
title_sort 481. evolution of carbapenem-resistant pseudomonas aeruginosa (cr-pa) genetic lineages and acquisition of β-lactamase enzymes
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811033/
http://dx.doi.org/10.1093/ofid/ofz360.554
work_keys_str_mv AT sakuraiaki 481evolutionofcarbapenemresistantpseudomonasaeruginosacrpageneticlineagesandacquisitionofblactamaseenzymes
AT dinhanq 481evolutionofcarbapenemresistantpseudomonasaeruginosacrpageneticlineagesandacquisitionofblactamaseenzymes
AT hansonblake 481evolutionofcarbapenemresistantpseudomonasaeruginosacrpageneticlineagesandacquisitionofblactamaseenzymes
AT shropshirewilliamc 481evolutionofcarbapenemresistantpseudomonasaeruginosacrpageneticlineagesandacquisitionofblactamaseenzymes
AT trantruct 481evolutionofcarbapenemresistantpseudomonasaeruginosacrpageneticlineagesandacquisitionofblactamaseenzymes
AT wangeraudrey 481evolutionofcarbapenemresistantpseudomonasaeruginosacrpageneticlineagesandacquisitionofblactamaseenzymes
AT ariascesara 481evolutionofcarbapenemresistantpseudomonasaeruginosacrpageneticlineagesandacquisitionofblactamaseenzymes
AT millerwilliamr 481evolutionofcarbapenemresistantpseudomonasaeruginosacrpageneticlineagesandacquisitionofblactamaseenzymes